These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant. Keshavarz R; Mousavi MA; Hassani C Pediatr Emerg Care; 2002 Feb; 18(1):22-4. PubMed ID: 11862133 [TBL] [Abstract][Full Text] [Related]
6. Posttransplant diabetes in pediatric recipients on tacrolimus. Shapiro R; Scantlebury V; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Fung JJ; Simmons RL; Starzl TE Transplantation; 1999 Mar; 67(5):771. PubMed ID: 10096540 [No Abstract] [Full Text] [Related]
7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
8. FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Carroll PB; Rilo H; Reyes J; Alejandro R; Zeng Y; Ricordi C; Tzakis A; Shapiro R; Starzl TE Transplant Proc; 1991 Dec; 23(6):3171-2. PubMed ID: 1721396 [No Abstract] [Full Text] [Related]
9. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. Tanabe K; Koga S; Takahashi K; Sonda K; Tokumoto T; Babazono T; Yagisawa T; Toma H; Kawai T; Fuchinoue S; Teraoka S; Ota K Transplant Proc; 1996 Jun; 28(3):1304-5. PubMed ID: 8658670 [No Abstract] [Full Text] [Related]
10. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
12. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient. Falkenstein K; Dunn S Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354 [No Abstract] [Full Text] [Related]
13. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus. Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; DeschĂȘnes G; Jacqz-Aigrain E Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Miller J; Mendez R; Pirsch JD; Jensik SC Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543 [TBL] [Abstract][Full Text] [Related]
16. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Satterthwaite R; Aswad S; Sunga V; Shidban H; Bogaard T; Asai P; Khetan U; Akra I; Mendez RG; Mendez R Transplantation; 1998 Feb; 65(3):446-9. PubMed ID: 9484771 [TBL] [Abstract][Full Text] [Related]
17. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Hoitsma AJ; Hilbrands LB Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494 [TBL] [Abstract][Full Text] [Related]
18. Evaluating mechanisms of post-transplant diabetes mellitus. van Hooff JP; Christiaans MH; van Duijnhoven EM Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024 [TBL] [Abstract][Full Text] [Related]